Equimed Pharma Bridge is AI Enabled Platform for accelerating entry of your idea

Integrated Expertise for U.S. Market Entry

Equimed Alliance combines regulatory, scientific and commercial expertise to support informed decision-making across development, approval and market entry - reducing risk and accelerating execution

01

Regulatory Pathway Strategy

NDA, ANDA, 505(b)(2), and DMF pathway assessment
Techno-commercial filing strategy and submission planning
Lifecycle support for NDA, sNDA, and ANDA programs

02

Biologics and Biosimilars strategy

Support for biologics, biosimilars, and interchangeable product filings
Guidance on development, scale-up, and manufacturing strategy
Partner scouting and U.S. launch planning

03

Formulation and CMC strategy

Cost-effective, scalable formulation strategy for U.S. launch
Competitor mapping to support product differentiation
CMC roadmap and supply chain planning for submission readiness

04

Regulatory submission and FDA strategy

NDA and ANDA dossier compilation in eCTD format
FDA query response and post-approval change support
Meeting preparation and petition documentation

05

IP & Exclusivity Strategy

Customized IP and launch strategy aligned with product goals
Freedom-to-operate and launch scenario planning
IP fencing and lifecycle strategy to maximize product value

06

Commercial Strategy & Partnerships

Techno-commercial strategy informed by regulatory and IP insights
Partner identification across API, FDF, CMO, and commercial networks
Tech transfer, scale-up, and U.S. launch planning support

07

Execution and Delivery

Cross-functional coordination across regulatory, CMC, IP, and commercial workstreams
Submission readiness support from planning through FDA engagement
Practical execution support at critical development and approval milestones

08

Launch and Lifecycle Management

U.S. launch planning aligned with regulatory and commercial priorities
Post-approval lifecycle strategy for NDA, sNDA, ANDA, and biosimilar products
Ongoing market, IP, and regulatory support to sustain product value

Partners

Who We Serve

Biosimilars and Biologics

Supporting development and regulatory strategy for biosimilars and complex biologic products.

Speciality and complex generics

Advising on regulatory pathways for complex formulations and value-added generic products.

International biopharma innovators

Helping global innovators navigate FDA pathways and prepare for successful U.S. market entry.

Pharmaceutical manufacturers

Collaborating with manufacturers and CMOs to ensure compliance, quality, and regulatory alignment.

Research and early stage innovators

Partnering with emerging companies to build a strong regulatory and commercial foundation.